Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016, Article ID 4025167, 8 pages
http://dx.doi.org/10.1155/2016/4025167
Research Article

Interleukin-27 as a Novel Biomarker for Early Cardiopulmonary Failure in Enterovirus 71-Infected Children with Central Nervous System Involvement

1Department of Sanitary Analysis, Dongguan Key Laboratory of Environmental Medicine, School of Public Health, Guangdong Medical University, Dongguan 523808, China
2Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Dongguan Scientific Research Center, Guangdong Medical University, Dongguan 523808, China
3Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai 200040, China
4Guangzhou Nansha Center for Disease Control and Prevention, Guangzhou 511458, China
5Guangzhou Nansha Central Hospital, Guangzhou 511458, China

Received 18 March 2016; Accepted 19 May 2016

Academic Editor: Mukesh Kumar

Copyright © 2016 Mingyuan Huang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P.-N. Huang and S.-R. Shih, “Update on enterovirus 71 infection,” Current Opinion in Virology, vol. 5, no. 1, pp. 98–104, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. S.-M. Wang and C.-C. Liu, “Update of enterovirus 71 infection: epidemiology, pathogenesis and vaccine,” Expert Review of Anti-Infective Therapy, vol. 12, no. 4, pp. 447–456, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Sarma, “Hand, foot, and mouth disease: current scenario and Indian perspective,” Indian Journal of Dermatology, Venereology and Leprology, vol. 79, no. 2, pp. 165–175, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. L.-C. Wang, C.-M. Kao, P. Ling, I.-J. Su, T.-M. Chang, and S.-H. Chen, “CD4 T-cell-independent antibody response reduces enterovirus 71 lethality in mice by decreasing tissue viral loads,” Clinical and Developmental Immunology, vol. 2012, Article ID 580696, 9 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Chi, Q. Sun, S. Wang et al., “Robust antiviral responses to enterovirus 71 infection in human intestinal epithelial cells,” Virus Research, vol. 176, no. 1-2, pp. 53–60, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. Z. Chen, R. Li, Z. Xie, G. Huang, Q. Yuan, and J. Zeng, “IL-6, IL-10 and IL-13 are associated with pathogenesis in children with Enterovirus 71 infection,” International Journal of Clinical and Experimental Medicine, vol. 7, no. 9, pp. 2718–2723, 2014. View at Google Scholar · View at Scopus
  7. Y. Zhang, H. Liu, L. Wang et al., “Comparative study of the cytokine/chemokine response in children with differing disease severity in enterovirus 71-induced hand, foot, and mouth disease,” PLoS ONE, vol. 8, no. 6, Article ID e67430, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. J. S. Stumhofer, E. D. Tait, W. J. Quinn III et al., “A role for IL-27p28 as an antagonist of gp130-mediated signaling,” Nature Immunology, vol. 11, no. 12, pp. 1119–1126, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. M. T. P. de Aquino, P. Kapil, D. R. Hinton et al., “IL-27 limits central nervous system viral clearance by promoting IL-10 and enhances demyelination,” The Journal of Immunology, vol. 193, no. 1, pp. 285–294, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Cao, R. Zhang, W. Zhang et al., “IL-27, a cytokine, and IFN-λ1, a type III IFN, are coordinated to regulate virus replication through type I IFN,” The Journal of Immunology, vol. 192, no. 2, pp. 691–703, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. Q. Chen, S. Swaminathan, D. Yang et al., “Interleukin-27 is a potent inhibitor of cis HIV-1 replication in monocyte-derived dendritic cells via a type i interferon-independent pathway,” PLoS ONE, vol. 8, no. 3, Article ID e59194, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Zhao, Y. Zhang, F. Xue, J. Xu, and Z. Fang, “Interleukin-27 rs153109 polymorphism and the risk for immune thrombocytopenia,” Autoimmunity, vol. 46, no. 8, pp. 509–512, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Zhang, M. Ma, Y. Yang et al., “Association between polymorphisms in IL27 and risk for CHD in a Chinese population,” Cardiology in the Young, vol. 26, no. 2, pp. 237–243, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. Z. Wang, L. Wang, R. Fan, J. Zhou, and J. Zhong, “Association of IL-27 gene three polymorphisms with Crohn's disease susceptibility in a Chinese Han population,” International Journal of Clinical and Experimental Pathology, vol. 7, no. 12, pp. 8952–8957, 2014. View at Google Scholar · View at Scopus
  15. Y. Shen, X.-D. Yuan, D. Hu et al., “Association between Interleukin-27 gene polymorphisms and susceptibility to allergic rhinitis,” Human Immunology, vol. 75, no. 9, pp. 991–995, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. B. Zhou, P. Zhang, T. Tang et al., “Polymorphisms and plasma levels of IL-27: impact on genetic susceptibility and clinical outcome of bladder cancer,” BMC Cancer, vol. 15, no. 1, article 433, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. Z. Zhang, B. Zhou, Y. Wu et al., “Prognostic value of IL-27 polymorphisms and the susceptibility to epithelial ovarian cancer in a Chinese population,” Immunogenetics, vol. 66, no. 2, pp. 85–92, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. Y.-P. Tao, W.-L. Wang, S.-Y. Li et al., “Associations between polymorphisms in IL-12A, IL-12B, IL-12Rβ1, IL-27 gene and serum levels of IL-12p40, IL-27p28 with esophageal cancer,” Journal of Cancer Research and Clinical Oncology, vol. 138, no. 11, pp. 1891–1900, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. J.-C. Zeng, W.-Y. Xiang, D.-Z. Lin et al., “Elevated HMGB1-related interleukin-6 is associated with dynamic responses of monocytes in patients with active pulmonary tuberculosis,” International Journal of Clinical and Experimental Pathology, vol. 8, no. 2, pp. 1341–1353, 2015. View at Google Scholar · View at Scopus
  20. J.-C. Zeng, D.-Z. Lin, L.-L. Yi et al., “BTLA exhibits immune memory for alphabeta T cells in patients with active pulmonary tuberculosis,” American Journal of Translational Research, vol. 6, no. 5, pp. 494–506, 2014. View at Google Scholar · View at Scopus
  21. J.-C. Zeng, Z. Zhang, T.-Y. Li et al., “Assessing the role of IL-35 in colorectal cancer progression and prognosis,” International Journal of Clinical and Experimental Pathology, vol. 6, no. 9, pp. 1806–1816, 2013. View at Google Scholar · View at Scopus
  22. Y. Li, R. Zhu, Y. Qian, and J. Deng, “The characteristics of blood glucose and WBC counts in peripheral blood of cases of hand foot and mouth disease in China: a systematic review,” PLoS ONE, vol. 7, no. 1, Article ID e29003, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. J.-A. Li, Z.-B. Chen, T.-G. Lv, and Z.-L. Han, “Genetic polymorphism of CCL2-2518, CXCL10-201, IL8+781 and susceptibility to severity of Enterovirus-71 infection in a Chinese population,” Inflammation Research, vol. 63, no. 7, pp. 549–556, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. Z. Liu, J.-Q. Liu, F. Talebian, L.-C. Wu, S. Li, and X.-F. Bai, “IL-27 enhances the survival of tumor antigen-specific CD8+ T cells and programs them into IL-10-producing, memory precursor-like effector cells,” European Journal of Immunology, vol. 43, no. 2, pp. 468–479, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Schneider, T. Yaneva, D. Beauseigle, L. El-Khoury, and N. Arbour, “IL-27 increases the proliferation and effector functions of human naïve CD8+ T lymphocytes and promotes their development into Tc1 cells,” European Journal of Immunology, vol. 41, no. 1, pp. 47–59, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Morishima, T. Owaki, M. Asakawa, S. Kamiya, J. Mizuguchi, and T. Yoshimoto, “Augmentation of effector CD8+ T cell generation with enhanced granzyme B expression by IL-27,” The Journal of Immunology, vol. 175, no. 3, pp. 1686–1693, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Do, A. Visperas, Y. O. Sanogo et al., “An IL-27/Lag3 axis enhances Foxp3+ regulatory T cell–suppressive function and therapeutic efficacy,” Mucosal Immunology, vol. 9, no. 1, pp. 137–145, 2015. View at Publisher · View at Google Scholar
  28. M.-S. Li, Z. Liu, J.-Q. Liu, X. Zhu, Z. Liu, and X.-F. Bai, “The Yin and Yang aspects of IL-27 in induction of cancer-specific T-cell responses and immunotherapy,” Immunotherapy, vol. 7, no. 2, pp. 191–200, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Wei, S. Xia, H. Sun et al., “Critical role of dendritic cell-derived IL-27 in antitumor immunity through regulating the recruitment and activation of NK and NKT cells,” The Journal of Immunology, vol. 191, no. 1, pp. 500–508, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Hirahara, K. Ghoreschi, X.-P. Yang et al., “Interleukin-27 priming of T cells controls il-17 production in trans via induction of the ligand PD-L1,” Immunity, vol. 36, no. 6, pp. 1017–1030, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. I. D. Mascanfroni, A. Yeste, S. M. Vieira et al., “IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39,” Nature Immunology, vol. 14, no. 10, pp. 1054–1063, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Zhou, J.-H. Qiu, T. Wang et al., “Interleukin 27 inhibits cytotoxic T-lymphocyte-mediated platelet destruction in primary immune thrombocytopenia,” Blood, vol. 124, no. 22, pp. 3316–3319, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. F. W. McNab, J. Ewbank, A. Howes et al., “Type I IFN induces IL-10 production in an IL-27—independent manner and blocks responsiveness to IFN-γ for production of IL-12 and bacterial killing in Mycobacterium tuberculosis—infected macrophages,” The Journal of Immunology, vol. 193, no. 7, pp. 3600–3612, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. A. C. Frank, X. Zhang, A. Katsounas, J. P. Bharucha, S. Kottilil, and T. Imamichi, “Interleukin-27, an anti-HIV-1 cytokine, inhibits replication of hepatitis C virus,” Journal of Interferon and Cytokine Research, vol. 30, no. 6, pp. 427–431, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. W. P. Chong, R. Horai, M. J. Mattapallil et al., “IL-27p28 inhibits central nervous system autoimmunity by concurrently antagonizing Th1 and Th17 responses,” Journal of Autoimmunity, vol. 50, pp. 12–22, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. S.-C. Chae, C.-S. Li, K. M. Kim et al., “Identification of polymorphisms in human interleukin-27 and their association with asthma in a Korean population,” Journal of Human Genetics, vol. 52, no. 4, pp. 355–361, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. N. Huang, L. Liu, X.-Z. Wang, D. Liu, S.-Y. Yin, and X.-D. Yang, “Association of interleukin (IL)-12 and IL-27 gene polymorphisms with chronic obstructive pulmonary disease in a Chinese population,” DNA and Cell Biology, vol. 27, no. 9, pp. 527–531, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Paradowska-Gorycka, B. Raszkiewicz, M. Jurkowska et al., “Association of single nucleotide polymorphisms in the IL27 gene with rheumatoid arthritis,” Scandinavian Journal of Immunology, vol. 80, no. 4, pp. 298–305, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. C.-S. Li, Q. Zhang, K.-J. Lee et al., “Interleukin-27 polymorphisms are associated with inflammatory bowel diseases in a Korean population,” Journal of Gastroenterology and Hepatology (Australia), vol. 24, no. 10, pp. 1692–1696, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Y. Oh, J. K. Sim, W. J. Jung et al., “Association between interleukin-27 polymorphisms and pulmonary tuberculosis,” International Journal of Tuberculosis and Lung Disease, vol. 19, no. 6, pp. 702–708, 2015. View at Publisher · View at Google Scholar · View at Scopus
  41. E. Zicca, A. Quirino, N. Marascio et al., “Interleukin 27 polymorphisms in HCV RNA positive patients: is there an impact on response to interferon therapy?” BMC Infectious Diseases, vol. 14, supplement 5, article S5, 2014. View at Google Scholar · View at Scopus
  42. Y.-S. Wei, Y. Lan, B. Luo, D. Lu, and H.-B. Nong, “Association of variants in the interleukin-27 and interleukin-12 gene with nasopharyngeal carcinoma,” Molecular Carcinogenesis, vol. 48, no. 8, pp. 751–757, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Zhang, X. Gao, Y. Wang, J. Jia, Q. Zhang, and Z. Ji, “Interleukin 27 -964A > G genetic polymorphism and serum IL-27p28 levels in Chinese patients with papillary thyroid cancer,” Tumor Biology, vol. 36, no. 10, pp. 8207–8211, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. Y.-J. Tang, J.-L. Wang, L.-G. Nong, C.-G. Lan, Z.-G. Zha, and P.-H. Liao, “Associations of IL-27 polymorphisms and serum IL-27p28 levels with osteosarcoma risk,” Medicine, vol. 93, no. 10, article e56, 2014. View at Publisher · View at Google Scholar · View at Scopus